Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Cancer Prev ; 5(2): 99-104, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8736076

RESUMEN

In a cohort of 25,000 women aged 40-65 years at intake in a periodic screening programme for breast cancer the occurrence of endometrial cancer was studied during a follow-up period of up to 18 years. The authors examined whether they could confirm the existence of a number of relationships between this cancer and some reproductive and anthropometric factors which had been found in several case-control studies and in a few cohort studies. A comparison was made between 147 cases of endometrial cancer occurring during the period of follow-up and a random sample of 900 women taken from the cohort (334 being premenopausal and 566 postmenopausal on the day of intake). An inverse relationship between number of children and endometrial cancer risk was found in the older group; the excess risk among nulliparous women was stronger in married than in single women. Late age at menopause (after age 52) was associated with increased risk. Use of oestrogenic drugs on day of intake for alleviating perimenopausal complaints (reported in 8% of women) increased risk, especially in the younger group. Body weight was positively associated with risk (with an odds ratio of 4 in those over 80 kg) among postmenopausal women. Because there appeared to be a moderately strong risk associated with tall height, especially among postmenopausal women, Quetelet's index performed less well than body weight itself. Nevertheless, subscapular and triceps skinfold thicknesses confirmed an effect of fatness on risk. These results are discussed with reference to other epidemiological studies, in particular two cohort studies from Norway. The effect of height, convincingly shown by Tretli and Magnus in 1990, is explained in a way which does not assume causal mechanisms operating at a young age: absolute fat mass rather than relative weight is regarded as the main determinant of risk in postmenopausal women.


Asunto(s)
Neoplasias de la Mama/epidemiología , Neoplasias Endometriales/epidemiología , Neoplasias Primarias Múltiples/epidemiología , Adulto , Factores de Edad , Constitución Corporal , Neoplasias de la Mama/prevención & control , Estudios de Cohortes , Estrógenos/uso terapéutico , Femenino , Humanos , Tamizaje Masivo , Menopausia , Persona de Mediana Edad , Países Bajos/epidemiología , Paridad , Factores de Riesgo
2.
Eur J Cancer Prev ; 5(2): 105-12, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8736077

RESUMEN

A cohort study has been carried out to investigate risk factors for cancer as well as hyperplasia of the endometrium. Over the 13 years for which we followed 25,000 women aged 40-65 (who took part in a population-based screening programme for breast cancer), 111 cases of endometrial cancer and 109 cases of endometrial hyperplasia were diagnosed. A comparison of the outcome between the two disease entities revealed that large body weight among postmenopausal women and the use of oestrogenic drugs at all ages were risk factors for both cancer and hyperplasia of the endometrium. However, reproductive histories and premenopausal steroid profiles differed. Steroid excretion determinations in urine samples collected years before diagnosis provided further evidence in favour of the hypothesis of unopposed action of oestrogens in the aetiology of endometrial cancer. In women who were to develop endometrial hyperplasia or cancer the obesity-oestrogen relationship was stronger than in those who remained free of endometrial disease during the period of follow-up. The possible significance of differences in aromatase activity among the obese is considered.


Asunto(s)
Hiperplasia Endometrial/epidemiología , Neoplasias Endometriales/epidemiología , Adulto , Factores de Edad , Constitución Corporal , Neoplasias de la Mama/prevención & control , Estudios de Cohortes , Hiperplasia Endometrial/fisiopatología , Hiperplasia Endometrial/orina , Neoplasias Endometriales/fisiopatología , Neoplasias Endometriales/orina , Estrógenos/uso terapéutico , Femenino , Hormonas Esteroides Gonadales/orina , Humanos , Tamizaje Masivo , Menopausia , Persona de Mediana Edad , Paridad , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA